Food and Drug Administration (FDA) has approved several long-term medications to help people lose weight, including: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) : These medications work by imitating the GLP-1 hormone, which appears naturally in the body
Some patients find that principles from low-FODMAP diets (which limit certain fermentable carbohydrates) may be helpful for short-term symptom management, though this should be done with professional guidance
Overview of the available GLP-1RAs listed according to their reported half-lives ( t 1/2 ) and the current clinical evidence of their effect in treatment of BAD Here, we review the scarce literature on the use of different GLP-1RAs in BAD treatment and discuss the potential of different GLP-1RAs in the context of their pharmacokinetic profiles, which we speculate may be important determinants of their mode of actions and, thus, pharmacodynamics in BAD
Los animales entrenaron 3 sesiones/semana sobre el tapiz rodante, y el tiempo de carrera hasta el agotamiento fue la referencia seleccionada como indicador de rendimiento de resistencia aerbica
Caution is needed when supplementing potassium in patients with impaired renal function
